NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma

Somnath Mukherjee, Christopher Nicholas Hurt*, Sarah Gwynne, David Sebag-Montefiore, Ganesh Radhakrishna, Simon Gollins, Maria Hawkins, Heike I. Grabsch, Gareth Jones, Stephen Falk, Ricky Sharma, Andrew Bateman, Rajarshi Roy, Ruby Ray, Jo Canham, Gareth Griffiths, Tim Maughan, Tom Crosby

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)38-46
Number of pages9
JournalEuropean Journal of Cancer
Volume74
DOIs
Publication statusPublished - Mar 2017

Keywords

  • Oesophageal
  • Chemotherapy
  • Radiotherapy
  • Surgery
  • Neo-adjuvant
  • Randomised phase II
  • PERIOPERATIVE CHEMOTHERAPY
  • CANCER
  • TRIAL
  • CHEMORADIOTHERAPY
  • OXALIPLATIN
  • FLUOROURACIL
  • CAPECITABINE
  • NEOADJUVANT
  • CARCINOMA
  • 5-FLUOROURACIL

Cite this

Mukherjee, S., Hurt, C. N., Gwynne, S., Sebag-Montefiore, D., Radhakrishna, G., Gollins, S., Hawkins, M., Grabsch, H. I., Jones, G., Falk, S., Sharma, R., Bateman, A., Roy, R., Ray, R., Canham, J., Griffiths, G., Maughan, T., & Crosby, T. (2017). NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma. European Journal of Cancer, 74, 38-46. https://doi.org/10.1016/j.ejca.2016.11.031